Article Details

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Retrieved on: 2021-07-22 01:18:45

Tags for this article:

Click the tags to see associated articles and topics

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research. View article details on HISWAI: https://www.news-medical.net/news/20210721/Combination-antibody-therapies-retain-potency-against-SARS-CoV-2-variants-FDA-HHS-research.aspx

Excerpt

“The continuing evolution of circulating SARS-CoV-2 variants, often containing substitutions known to confer resistance to several monoclonal ...

Article found on: www.news-medical.net

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up